These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases. Bertini R, Roscigno M, Freschi M, Strada E, Petralia G, Pasta A, Matloob R, Sozzi F, Da Pozzo L, Colombo R, Guazzoni G, Doglioni C, Montorsi F, Rigatti P. J Urol; 2009 May; 181(5):2027-32. PubMed ID: 19286201 [Abstract] [Full Text] [Related]
3. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma. Yoo C, Song C, Hong JH, Kim CS, Ahn H. J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101 [Abstract] [Full Text] [Related]
4. Does stage T3a renal cell carcinoma embrace a homogeneous group of patients? Gofrit ON, Shapiro A, Pizov G, Landau EH, Katz R, Zorn KC, Pode D. J Urol; 2007 May; 177(5):1682-6. PubMed ID: 17437782 [Abstract] [Full Text] [Related]
6. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma. Wagner B, Patard JJ, Méjean A, Bensalah K, Verhoest G, Zigeuner R, Ficarra V, Tostain J, Mulders P, Chautard D, Descotes JL, de la Taille A, Salomon L, Prayer-Galetti T, Cindolo L, Valéri A, Meyer N, Jacqmin D, Lang H. Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951 [Abstract] [Full Text] [Related]
7. Invasion of renal sinus fat is not an independent predictor of survival in pT3a renal cell carcinoma. Poon SA, Gonzalez JR, Benson MC, McKiernan JM. BJU Int; 2009 Jun; 103(12):1622-5. PubMed ID: 19154464 [Abstract] [Full Text] [Related]
8. Perinephric and renal sinus fat infiltration in pT3a renal cell carcinoma: possible prognostic differences. Bedke J, Buse S, Pritsch M, Macher-Goeppinger S, Schirmacher P, Haferkamp A, Hohenfellner M. BJU Int; 2009 May; 103(10):1349-54. PubMed ID: 19076147 [Abstract] [Full Text] [Related]
9. Impact of several histopathological prognosticators and local tumour extension on oncological outcome in pT3b/c N0M0 renal cell carcinoma. Roos FC, Weirich J, Victor A, Elsässer A, Brenner W, Biesterfeld S, Hampel C, Thüroff JW. BJU Int; 2009 Aug; 104(4):461-9. PubMed ID: 19338563 [Abstract] [Full Text] [Related]
12. Reevaluation of renal cell carcinoma and perirenal fat invasion only. Jeon HG, Jeong IG, Kwak C, Kim HH, Lee SE, Lee E. J Urol; 2009 Nov; 182(5):2137-43. PubMed ID: 19758661 [Abstract] [Full Text] [Related]
13. The prognostic value of fat invasion and tumor expansion in the hilar veins in pT3a renal cell carcinoma. Stühler V, Rausch S, Kroll K, Scharpf M, Stenzl A, Bedke J. World J Urol; 2021 Sep; 39(9):3367-3376. PubMed ID: 33638011 [Abstract] [Full Text] [Related]
14. Microscopic vascular invasion is the most relevant prognosticator after radical nephrectomy for clinically nonmetastatic renal cell carcinoma. Van Poppel H, Vandendriessche H, Boel K, Mertens V, Goethuys H, Haustermans K, Van Damme B, Baert L. J Urol; 1997 Jul; 158(1):45-9. PubMed ID: 9186320 [Abstract] [Full Text] [Related]
15. Tumor size and Fuhrman grade further enhance the prognostic impact of perinephric fat invasion and renal vein extension in T3a staging of renal cell carcinoma. Chen K, Lee BL, Huang HH, Tan BY, Lee LS, Ng LG, Lau W, Yuen JS. Int J Urol; 2017 Jan; 24(1):51-58. PubMed ID: 27757999 [Abstract] [Full Text] [Related]
16. Evaluation of the prognostic significance of perirenal fat invasion and tumor size in patients with pT1-pT3a localized renal cell carcinoma in a comprehensive multicenter study of the CORONA project. Can we improve prognostic discrimination for patients with stage pT3a tumors? Brookman-May SD, May M, Wolff I, Zigeuner R, Hutterer GC, Cindolo L, Schips L, De Cobelli O, Rocco B, De Nunzio C, Tubaro A, Coman I, Truss M, Dalpiaz O, Feciche B, Figenshau RS, Madison K, Sánchez-Chapado M, Santiago Martin Mdel C, Salzano L, Lotrecchiano G, Zastrow S, Wirth M, Sountoulides P, Shariat S, Waidelich R, Stief C, Gunia S, CORONA Project, European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Group. Eur Urol; 2015 May; 67(5):943-51. PubMed ID: 25684695 [Abstract] [Full Text] [Related]
19. A new staging system for locally advanced (pT3-4) renal cell carcinoma: a multicenter European study including 2,000 patients. Ficarra V, Galfano A, Guillé F, Schips L, Tostain J, Mejean A, Lang H, Mulders P, De La Taille A, Chautard D, Descotes JL, Cindolo L, Novara G, Rioux-Leclercq N, Zattoni F, Artibani W, Patard JJ. J Urol; 2007 Aug; 178(2):418-24; discussion 423-4. PubMed ID: 17561128 [Abstract] [Full Text] [Related]
20. Charlson co-morbidity index as a predictor of outcome after surgery for renal cell carcinoma with renal vein, vena cava or right atrium extension. Gettman MT, Boelter CW, Cheville JC, Zincke H, Bryant SC, Blute ML. J Urol; 2003 Apr; 169(4):1282-6. PubMed ID: 12629343 [Abstract] [Full Text] [Related] Page: [Next] [New Search]